Compare Moderna, Inc. (MRNA) vs Verisign, Inc. (VRSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Verisign, Inc. — how do they compare? Moderna, Inc. trades at $63.5 (market cap $25.42B), while Verisign, Inc. trades at $286.75 (market cap $25.58B). The key difference: Moderna, Inc. and Verisign, Inc. are close in size by market cap, and Verisign, Inc. pays a 1.15% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | VRSN | |
|---|---|---|
Market Cap | $25.42B | $25.58B |
Sector | Health | Technology |
52-Week High | $81.80 | $310.00 |
52-Week Low | $22.36 | $211.49 |
Enterprise Value | $21.57B | $26.88B |
Dividend Yield | — | 1.15% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →
